P-glycoproteins in pathology: the multidrug resistance gene family in humans.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Human Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0046-8177(90)90073-EPMID 1967244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

  2012cited by this paper
• The band 3-rich membrane of llama erythrocytes: Studies on cell shape and the organization of membrane proteins

  2005cited by this paper
• Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells

  2004cited by this paper
• Expression of the Multidrug Resistance Gene in Human Cancer

  1991cited by this paper
• Multidrug resistance in the laboratory and clinic.

  1989cited by this paper
• Structure and expression of the human MDR (P-glycoprotein) gene family

  1989cited by this paper
• Increased P‐glycoprotein expression and multidrug‐resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage

  1989cited by this paper
• Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

  1989cited by this paper
• Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia

  1989cited by this paper
• Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.

  1989cited by this paper
• The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein

  1989cited by this paper
• P-glycoprotein and multidrug resistance in cancer chemotherapy.

  1989cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• Multidrug resistance in the laboratory and clinic.

  1989cited by this paper
• Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.

  1989cited by this paper
• Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Expression of Multidrug Resistance Gene in Human Cancers

  1989cited by this paper
• Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.

  1989cited by this paper
• Expression of a human multidrug resistance gene in ovarian carcinomas.

  1989cited by this paper
• Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.

  1989cited by this paper
• Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

  1989cited by this paper
• The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

  1989cited by this paper
• Multidrug resistance: molecular biology and clinical relevance.

  1989cited by this paper
• The multidrug transporter: rapid modulation of efflux activity monitored in single cells by the morphologic effects of vinblastine and daunomycin.

  1989cited by this paper
• Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.

  1989cited by this paper
• MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants.

  1989cited by this paper
• Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

  1989cited by this paper
• Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.

  1989cited by this paper
• Immunohistochemical detection and quantitation of p-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation

  1989cited by this paper
• Identification of members of the P-glycoprotein multigene family

  1989cited by this paper
• Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum.

  1989cited by this paper
• Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation.

  1989cited by this paper
• Multidrug Resistance: Molecular Biology Clinical Relevance

  1989cited by this paper
• Multidrug resistance during chemical carcinogenesis: a mechanism revealed?

  1988cited by this paper
• Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase.

  1988cited by this paper
• MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY

  1988cited by this paper
• Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.

  1988cited by this paper
• Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes.

  1988cited by this paper
• Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

  1988cited by this paper
• Genetics of multidrug resistance.

  1988cited by this paper
• An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.

  1988cited by this paper
• The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus.

  1988cited by this paper
• Cortical flow in animal cells.

  1988cited by this paper
• Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells

  1988cited by this paper
• Sequence of mdr3 cDNA encoding a human P-glycoprotein.

  1988cited by this paper
• Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance

  1988cited by this paper
• Resistance of multidrug‐resistant lines to natural killer‐like cell‐mediated cytotoxicity

  1988cited by this paper
• Altered plasma membrane ultrastructure in multidrug-resistant cells.

  1988cited by this paper
• A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.

  1988cited by this paper
• Mechanism of multidrug resistance.

  1988cited by this paper
• Focal adhesions and cell-matrix interactions.

  1988cited by this paper
• Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial.

  1988cited by this paper
• The multidrug transporter, a double-edged sword.

  1988cited by this paper
• Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.

  1988cited by this paper
• Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton.

  1988cited by this paper
• Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics.

  1988cited by this paper
• 14 – Different Mechanisms of Multiple Drug Resistance in Two Human Leukemic Cell Lines

  1988cited by this paper
• 4 – Cellular Concomitants of Multidrug Resistance

  1988cited by this paper
• Multidrug resistance.

  1988cited by this paper
• The human mdr3 gene encodes a novel P‐glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver.

  1987cited by this paper
• Evidence that multidrug resistance in Chinese hamster ovary cells is associated with alterations in the endoplasmic reticulum.

  1987cited by this paper
• Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

  1987cited by this paper
• Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

  1987cited by this paper
• Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

  1987cited by this paper
• Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.

  1987cited by this paper
• Survival strategies of bacteria in the natural environment.

  1987cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells.

  1987cited by this paper
• Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver.

  1987cited by this paper
• The cell biology of multiple drug resistance.

  1987cited by this paper
• Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells.

  1987cited by this paper
• Molecular mechanism of multidrug resistance in tumor cells.

  1987cited by this paper
• Multiple-drug resistance in human cancer.

  1987cited by this paper
• Expression of a multidrug-resistance gene in human tumors and tissues.

  1987cited by this paper
• Localization of the human multiple drug resistance gene, MDR1, to 7q21.1

  1987cited by this paper
• P-glycoprotein in human sarcoma: evidence for multidrug resistance.

  1987cited by this paper
• Expression of hamster P-glycoprotein and multidrug resistance in DNA-mediated transformants of mouse LTA cells

  1987cited by this paper
• Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins.

  1987cited by this paper
• Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.

  1987cited by this paper
• Optical microscope system for standardized cell measurements and analyses.

  1987cited by this paper
• Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody.

  1987cited by this paper
• Multidrug resistance.

  1986cited by this paper
• Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

  1986cited by this paper
• Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.

  1986cited by this paper
• Treatment of refractory multiple myeloma and considerations for future therapy.

  1986cited by this paper
• Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells.

  1986cited by this paper
• Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

  1986cited by this paper
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

  1986cited by this paper
• Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.

  1986cited by this paper
• Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene

  1986cited by this paper
• Structural aspects of the red cell anion exchange protein.

  1986cited by this paper
• Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.

  1986cited by this paper
• Verapamil Reversal of Clinical Doxorubicin Resistance in Human Cancer A Wilshire Oncology Medical Group Pilot Phase I‐II Study

  1986cited by this paper
• Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

  1986cited by this paper
• Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

  1986cited by this paper
• The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein.

  1986cited by this paper
• A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria

  1986cited by this paper
• Chromosome-mediated gene transfer of multidrug resistance

  1986cited by this paper
• Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

  1986cited by this paper

• Chemosensitizing effect of maitake mushroom extract on carmustine cytotoxicity in human bladder cancer cells

  2020cites this paper
• Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.

  2020cites this paper
• The Impact of Melatonin on Colon Cancer Cells’ Resistance to Doxorubicin in an In Vitro Study

  2017cites this paper
• The roll of chemoresistance in solid tumors

  2016cites this paper
• New insights into the mechanisms of multidrug resistance in cancers.

  2015cites this paper
• Molecular mechanisms of chemoresistance in osteosarcoma (Review)

  2014influential citation
• Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells

  2014cites this paper
• Identificaçao de marcador embrionário em tumor de córtex adrenal de crianças

  2013cites this paper
• MDCK Cells and Other Cell‐Culture Models of Oral Drug Absorption

  2011cites this paper
• Natural health products and cancer chemotherapy and radiation therapy

  2011cites this paper
• Novel in vitro cell culture models for studying pharmacokinetic drug-drug interactions following oral administration

  2011cites this paper
• Association between ABCB1 (MDR1) Gene 3435 C>T Polymorphism and Colchicine Unresponsiveness of FMF Patients

  2011cites this paper
• Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells

  2011cites this paper
• Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients

  2009cites this paper
• The pathogenesis of cancer metastasis: Relevance to therapy

  2009cites this paper
• Therapeutic Targeting of ATP7B in Ovarian Carcinoma

  2009cites this paper
• Establishment of Transplantable Biliary Cancer Lines

  2009cites this paper
• Cancer Therapy: Preclinical Therapeutic Targeting of ATP7B in Ovarian Carcinoma

  2009cites this paper
• Clinical study of multi-drug resistance gene (MDR1) expression in primary ovarian cancer

  2008cites this paper
• CHAPTER 30 – Effects of Therapy on Cytologic Specimens

  2008cites this paper
• Auswirkungen der obstruktiven Cholestase auf die intestinale Expression von MRP2 bei Ratten und Menschen

  2007cites this paper
• Technical Advances New Immunohistochemical "Sandwich" Staining Method for mdrl P-Glycoprotein Detection with JSB-1 Monoclonal Antibody in Formalin-Fixed, Paraffin-Embedded Human Tissues

  2007cites this paper
• MDR- and CYP3A4-mediated drug-herbal interactions.

  2006cites this paper
• Nuclear Magnetic Resonance and Toxicity Studies P 31 Multidrug-resistant MCF-7 Human Breast Cancer Cells : Action of Gossypol and Rhodamine 123 on Wild Type and Updated Version

  2006cites this paper
• Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.

  2006cites this paper
• Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma

  2006cites this paper
• Immunocytochemical detection of P-glycoprotein in the management of malignant effusions

  2005cites this paper
• P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.

  2005cites this paper
• Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients

  2005cites this paper
• GLYCOPROTEIN IN MALIGNANT MESOTHELIUM OF THE PLEURA USING THE MESOTHELIOMA AND IN NON-NEOPLASTIC MURINE MONOCLONAL ANTIBODY JSB-1

  2005cites this paper
• Prognostic implication of immunodetection of P glycoprotein in Ewing's sarcoma

  2005cites this paper
• Establishment of a transplantable carcinoma arising from the intrahepatic bile duct in Syrian golden hamsters

  2005cites this paper
• Study of novel dual topoisomerase poisons as potential anti-cancer drugs

  2005cites this paper
• Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA

  2005cites this paper
• A Mathematical Simulation to Explain the Coordinated Functions of Efflux and Metabolism Limiting the Transport of Anti-HIV Agents Across Caco-2 Cells

  2004cites this paper
• Modulation of Multidrug-Resistance-Associated P-Glycoprotein in Human U-87 MG and HUV-ECC Cells with Antisense Oligodeoxynucleotides to MDR1 mRNA

  2004cites this paper
• Chemosensitivity and cytokine sensitivity of malignant mesothelioma

  2004cites this paper
• Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome.

  2004cites this paper
• The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells

  2004cites this paper
• Molecular analysis of the multidrug transporter

  2004cites this paper
• Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas

  2004cites this paper
• Development of the Blood-Brain Barrier

  2003cites this paper
• Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients.

  2003cites this paper
• Expression of Multidrug Resistance-Associated Markers, Their Relation to Quantitative Pathologic Tumour Characteristics and Prognosis in Advanced Ovarian Cancer

  2002cites this paper
• Monoclonal antibodies as a tool for structure-function studies of the MDR1-P-glycoprotein.

  2002cites this paper
• CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.

  2002cites this paper
• Overcoming Multiple Drug Resistance with Anti-Pgp Carrier

  2002cites this paper
• Chemosensitization of Carmustine with Maitake β-Glucan on Androgen-Independent Prostatic Cancer Cells: Involvement of Glyoxalase I

  2002cites this paper
• P‐glycoprotein, lung resistance‐related protein and multidrug resistance‐associated protein in de novo adult acute lymphoblastic leukaemia

  2002cites this paper
• Critical determinants of metastasis.

  2002cites this paper
• [Multidrug resistance: a century after "606"].

  2001cites this paper
• Les gènes MDR en rhumatologie, un rôle immunologique ou pharmacologique

  2000cites this paper
• Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.

  2000cites this paper
• Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

  2000cites this paper
• Evolutionary malignant resistance of cells to damaging factors as common biological defence mechanism in neoplastic development. Review of conception.

  2000cites this paper
• Phénotype MDR-I de multirésistance aux traitements de fond dans les maladies rhumatismales auto-immunes : Première partie : une activité accrue de la P-glycoprotéine lymphocytaire pourrait influencer l'évolution de la polyarthrite rhumatdïde

  2000cites this paper
• Restoration of P-glycoprotein function is involved in the increase of natural killer activity with exogenous interleukin-15 in human immunodeficiency virus-infected individuals.

  2000cites this paper
• Multidrug resistances genes in rheumatology. Is their role immunological or pharmacological?

  2000cites this paper
• Phénotype MDR-I de multirésistance aux traitements de fond dans les maladies rhumatismales auto-immunes: Deuxième partie : une activité accrue de la P-glycoprotéine lymphocytaire semble s'accompagner de besoins plus importants en glucocorticoïdes dans le lupus érythémateux disséminé

  2000cites this paper
• P‐glycoprotein (PGP), lung resistance‐related protein (LRP) and multidrug resistance‐associated protein (MRP) expression in acute promyelocytic leukaemia

  2000cites this paper
• ects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

  2000cites this paper
• Multidrug resistance transporters and modulation

  2000cites this paper
• E V ects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells

  2000cites this paper
• Modelling in tumour biology part II: modelling cancer therapy.

  2000cites this paper
• P-Glycoprotein Levels Predict Poor Outcome in Patients With Osteosarcoma

  2000cites this paper
• P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications

  1999cites this paper
• Liposome‐encapsulated daunorubicin for PGP‐related multidrug resistance

  1999cites this paper
• Critical determinants of cancer metastasis: rationale for therapy

  1999cites this paper
• Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.

  1999cites this paper
• P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.

  1998cites this paper
• Recent Aspects in the Diagnosis and Prognosis of Bladder Cancer

  1998cites this paper
• Molecular analysis of the multidrug transporter, P-glycoprotein

  1998cites this paper
• [Treosulfan displays cytotoxic effect on spheroids of primary cell cultures of renal cell carcinoma independent of p-glycoprotein expression].

  1998cites this paper
• Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia

  1998cites this paper
• Treosulfan shows cytotoxic effect on spheroids from primary cell cultures of kidney cell carcinomas independently of P-glycoprotein expression

  1998cites this paper
• Clinical study of multi-drug resistance gene (MDR1) expression in primary ovarian cancer.

  1998cites this paper
• Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.

  1998cites this paper
• Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier

  1998cites this paper
• P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.

  1998cites this paper
• Subtractive hybridization cloning: an efficient technique to detect overexpressed mRNAs in diabetic nephropathy.

  1998cites this paper
• Acute lymphoblastic leukemia with maturation–a new entity with clinical significance

  1998cites this paper
• Differential activity of P‐glycoprotein in normal blood lymphocyte subsets

  1998cites this paper
• Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.

  1998cites this paper
• P‐Glycoprotein Is Positively Correlated with p53 Protein Accumulation in Human Colorectal Cancers

  1997cites this paper
• Sensitive immunofluorescence detection of the expression of P-glycoprotein in malignant cells.

  1997cites this paper
• Critical Determinants of Human Colon Cancer Metastasis

  1997cites this paper
• P‐glycoprotein (PGP) and lung resistance‐related protein (LRP) expression and function in leukaemic blast cells

  1997cites this paper
• Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.

  1997cites this paper
• P‐glycoprotein expression in cartilaginous tumors

  1997cites this paper
• Role of P-glycoprotein in chemoresistant superficial bladder tumours.

  1997cites this paper
• P‐Glycoprotein as a Prognostic Indicator in Pre- and Postchemotherapy Ovarian Adenocarcinoma

  1997cites this paper
• Intratumoral heterogeneity for and epigenetic modulation of mdr-1 expression in murine melanoma

  1997cites this paper
• Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.

  1997cites this paper
• De novo expression of P-glycoprotein associated with poor prognosis in high grade non-Hodgkin's lymphoma.

  1997cites this paper
• Polymorphic expression of multidrug resistance mRNA in lung parenchyma of nonpregnant and pregnant rats: a comparison to cystic fibrosis mRNA expression.

  1997cites this paper
• Classical multidrug resistance in acute myeloid leukaemia

  1997cites this paper
• Surface P-glycoprotein expression on peripheral lymphocyte subpopulations from HIV-infected patients.

  1997cites this paper
• Molecular Pathology of Gastroenterological Cancer

  1997cites this paper
• Identification of a new P-glycoprotein-like ATP-binding cassette transporter gene that is overexpressed during hepatocarcinogenesis.

  1997cites this paper
• Multidrug resistance in acute leukemia: a comparison of different diagnostic methods

  1997cites this paper